CSRNP3 and neoplasm: The anti‐CSF2 antibody or lnc‐CSRNP3 knockout significantly reduced the CSF2 content in mouse plasma and the lnc‐CSRNP3 expression in xenograft tissues, as well as markedly decreased the tumor volume and tumor weight (Figure 4G–L).